Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Merck
McKinsey
Baxter
QuintilesIMS
US Army
Deloitte
Medtronic
UBS
US Department of Justice

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022029

« Back to Dashboard

NDA 022029 describes SALONPAS, which is a drug marketed by Hisamitsu Pharm Co and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the SALONPAS profile page.

The generic ingredient in SALONPAS is menthol; methyl salicylate. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the menthol; methyl salicylate profile page.
Summary for 022029
Tradename:SALONPAS
Applicant:Hisamitsu Pharm Co
Ingredient:menthol; methyl salicylate
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 022029
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SALONPAS menthol; methyl salicylate PATCH;TOPICAL 022029 NDA Hisamitsu Pharmaceutical Co., Inc. 46581-670 46581-670-15 3 POUCH in 1 BOX (46581-670-15) > 5 PATCH in 1 POUCH
SALONPAS menthol; methyl salicylate PATCH;TOPICAL 022029 NDA Hisamitsu Pharmaceutical Co., Inc. 46581-670 46581-670-05 1 POUCH in 1 BOX (46581-670-05) > 5 PATCH in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:PATCH;TOPICALStrength3%;10%
Approval Date:Feb 20, 2008TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Jan 3, 2030Product Flag?YSubstance Flag?Delist Request?
Patent:➤ SubscribePatent Expiration:Aug 1, 2027Product Flag?YSubstance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:PATCH;TOPICALStrength3%;10%
Approval Date:Nov 5, 2012TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Jan 3, 2030Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Healthtrust
McKesson
Johnson and Johnson
Dow
Julphar
Chinese Patent Office
Queensland Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot